PNPLA4 Antikörper (AA 1-103) (HRP)
-
- Target Alle PNPLA4 Antikörper anzeigen
- PNPLA4 (Patatin-Like phospholipase Domain Containing 4 (PNPLA4))
-
Bindungsspezifität
- AA 1-103
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser PNPLA4 Antikörper ist konjugiert mit HRP
-
Applikation
- ELISA
- Kreuzreaktivität
- Human
- Aufreinigung
- >95%, Protein G purified
- Immunogen
- Recombinant Human G0/G1 switch protein 2 protein (1-103AA)
- Isotyp
- IgG
- Top Product
- Discover our top product PNPLA4 Primärantikörper
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4 - Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C,-80 °C
- Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Target
- PNPLA4 (Patatin-Like phospholipase Domain Containing 4 (PNPLA4))
- Andere Bezeichnung
- GS2 (PNPLA4 Produkte)
- Synonyme
- PNPLA4 antikoerper, DXS1283E antikoerper, GS2 antikoerper, iPLA2eta antikoerper, patatin like phospholipase domain containing 4 L homeolog antikoerper, patatin like phospholipase domain containing 4 antikoerper, pnpla4.L antikoerper, PNPLA4 antikoerper
- Hintergrund
-
Background: Promotes apoptosis by binding to BCL2, hence preventing the formation of protective BCL2-BAX heterodimers.
Aliases: G0/G1 switch regulatory protein 2 antibody, G0/G1switch 2 antibody, G0s2 antibody, G0S2_HUMAN antibody, OTTHUMP00000034644 antibody, Putative lymphocyte G0/G1 switch protein 2 antibody, RP1 28O10.2 antibody
- UniProt
- P27469
-